Scout Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Scout Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-91,123	Closed	-$13M	–	282
2019 Q2	$13M	Sell	91,123 -131,150	-59%	-$17.6M	0.25%	136
2019 Q1	$31.8M	Sell	222,273 -218,883	-50%	-$28.5M	0.65%	44
2018 Q4	$54.7M	Buy	+441,156	New	+$65.4M	1.37%	12

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Scout Investments's JAZZ Position: Q3 2019 in Review

Scout Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 91,123 shares — an estimated $13M sold.

Scout Investments first reported a position in JAZZ in Q4 2018 and held it in 3 quarters. The position peaked at $54.7M in Q4 2018. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

Scout Investments reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Scout Investments sold 91,123 Jazz Pharmaceuticals shares in Q3 2019, an estimated $13M.
Scout Investments first reported a position in Jazz Pharmaceuticals in Q4 2018 and held it in 3 quarters.
Scout Investments's Jazz Pharmaceuticals position peaked at $54.7M in Q4 2018.
406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Scout Investments's 13F filing for Q3 2019, filed 8 Oct 2019.